STOREDB:STUDY1078 Myeloid leukaemia and Harderian gland tumours in mice after X-ray and neutron exposure [DOI:10.20348/STOREDB/1078]
|Myeloid leukaemia and Harderian gland tumours in mice after X-ray and neutron exposure|
|Published: Open access to everyone|
|BIOLOGICAL SAMPLE AVAILABLE|
|Purpose: To determine dose effect relationships for myeloid leukemia and Harderian gland tumors .
Status: 1989 - 1992, X-rays terminated
Treatment: Single exposure to 250 kVp X-rays (126 mGy/min, 1.5 mm HVL)
Dosimetry: Twin ionization chamber ENDIP
Endpoints: Life-span study (spontaneous death) with macroscopic/microscopic pathology
Animal: Male CBA/H/Cne mice aged 3 months
Results: Harderian glands transplanted into the fat pad of isogenic recipients were used to quantitatively study cell survival and malignant transformation after X-ray exposure. The in vivo survival curve of the gland cells yielded a Do of 1.83 Gy and an extrapolation number of 7.23. The dose response for cell transplantation in vivo was compared with that for lesions in glands irradiated in situ. A high incidence of epithelial hyperplasia with severe dysplasia was observed in transplantation nodules after X-irradiation. The rate of gland tumors was significantly increased in whole-body-irradiated animals with a maximum incidence after 3 Gy. The risk of transformation per surviving cell was estimated for both dysplastic lesions and tumors. These results approximated a dose-squared relationship in both cases, suggesting a common induction mechanism at the cellular level. Myeloid leukemia was observed at all doses in whole body irradiated mice, and the maximum tumor incidence was reached at doses around 3 Gy.
STOREDB:DATASET1118 Link to data and details in ERA [DOI:10.20348/STOREDB/1078/1118]
Created on:2017-04-25 10:35:05 Modified On:2017-04-25 10:35:05
|Link to data and details in ERA|
|LINK TO FILE|